Tonix Pharmaceuticals Holding Corp. Share Price

Tonix Pharmaceuticals Holding Corp. Share Price

NASDAQ: TNXP | Micro Cap
$5.27
-$0.10 (-1.77%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tonix Pharmaceuticals Holding Corp. Stock Performance

Open
$5.45
Prev. Close
$5.37
Circuit Range
N/A
Day Range
$5.21 - $5.51
Year Range
$5.02 - $20.49
Volume
42,590
Average Traded
$5.35

Tonix Pharmaceuticals Holding Corp. Share Price Today

As of 30 October 2026, Tonix Pharmaceuticals Holding Corp.'s share price is $5.27. The stock opened at $5.45, compared to its previous close of $5.37. During today's trading session, Tonix Pharmaceuticals Holding Corp.'s share price traded between $5.21 and $5.51, with an average price of $5.36. Over the past 52 weeks, the stock has recorded a high of $20.49 and a low of $5.02. In terms of performance, Tonix Pharmaceuticals Holding Corp.'s share price has declined by 59.21% over the last six months and is down 71.69% on a year-on-year basis.

Tonix Pharmaceuticals Holding Corp. Share Price Chart

Line chart of the Tonix Pharmaceuticals Holding Corp. price trend over the selected period. The price fell overall, ranging from 5.21 to 5.51, ending at 5.27.
$5.21$5.51
L
Show Current Price
H

Tonix Pharmaceuticals Holding Corp. Stock Fundamentals & Key Indicators

Market Cap
$44.85M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-9.31
Revenue (TTM)
$13.11B
Return On Equity (TTM)
-71.83%
Profit Margin
-946.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-26.68%

Tonix Pharmaceuticals Holding Corp. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$3.29$5.39$6.88$13.54
Net Profit-$32.01-$46.91-$40.19-$40.55
Net Profit Margin-972.95%-870.32%-584.16%-299.48%
Income ChangeN/A-46.55%14.33%-0.90%

Tonix Pharmaceuticals Holding Corp. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$7.77$10.09$13.11
Net Profit-$116.88-$116.66-$130.04-$124.02
Net Profit MarginN/A-1501.42%-1288.80%-946.00%
Income ChangeN/A0.19%-11.47%4.63%

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Tonix Pharmaceuticals Holding Corp. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$9.68
$5.29
-45.64%
Sep 2026
$13.92
$9.74
-28.22%
Aug 2026
$10.01
$13.57
+35.16%
Jul 2026
$12.80
$10.04
-21.19%
Jun 2026
$12.27
$12.74
+3.07%
May 2026
$13.03
$12.36
-4.33%
Apr 2026
$14.52
$12.92
-6.10%
Mar 2026
$13.42
$13.76
-1.61%
Feb 2026
$17.12
$13.98
-18.74%
Jan 2026
$16.36
$17.21
+10.46%
Dec 2025
$15.38
$15.58
-2.20%
Nov 2025
$18.51
$15.93
-14.42%

TNXP Share Price FAQs